Home Antibody All anti-ELOVL7 antibodies
Also for ELOVL7 (NM_001104558)
|ELOVL7 antibody was raised against a 15 amino acid peptide near the amino terminus of human ELOVL7.|
|WB, IHC, IF
||WB: 1 ug/ml, IHC: 5 ug/ml, IF: 20 ug/ml
|PBS containing 0.02% sodium azide.|
|Affinity chromatography purified via peptide column
|Homo sapiens ELOVL fatty acid elongase 7 (ELOVL7), transcript variant 2|
|Lipogenesis is a key event in the energy storage system and is controlled by the transcription factor sterol regulatory element-binding protein (SREBP)-1. Elongation of very long chain fatty acids protein 7 (ELOVL7) is a member of fatty acyl-CoA elongase gene family that elongates saturated very-long-chain fatty acids (SVLFA, C20:0-) and has been suggested to be involved in prostate cancer growth through saturated long-chain fatty acid metabolism. The metabolic pathways of long-chain fatty acids play an important role in the maintenance of membrane lipid composition and the generation of cell signaling precursor molecules such as eicosanoids and sphingosine-1 phosphate. Overexpression of ELOVL7 results in lipid accumulation in differentiated adipocytes; its expression is regulated by the microRNA miR-219.|
* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
Western blot analysis of ELOVL7 in human liver tissue lysate with ELOVL7 antibody at 1 ug/mL.
Immunohistochemistry of ELOVL7 in human liver tissue with ELOVL7 antibody at 5 ug/mL.
Immunofluorescence of ELOVL7 in human liver tissue with ELOVL7 antibody at 20 ug/mL.